Skip to main content

5-Hydroxy-L-tryptophan


Basic information
Metabolite name

5-Hydroxy-L-tryptophan

HMDB0000472
C00643
144
Synonyms

5-hydroxytryptophan

No. of studies

20

 

Relationship between 5-Hydroxy-L-tryptophan and depression (count: 20)
Study Study Type Comparison groups Tissue Organism Up/Down regulated
Study M1008 Type2 CCFM1025 group vs. placebo group Faece Human Up
Study M1040 Type2 CUMS + fluoxetine group vs. CUMS group Brain Sprague-Dawley rat Up
Study M1040 Type2 CUMS + Roseburia inulinivorans group vs. CUMS group Brain Sprague-Dawley rat Up
Study M1040 Type2 CUMS + Bacteroides uniformis group vs. CUMS group Brain Sprague-Dawley rat Up
Study M1045 Type1 anxiety and depression group vs. control group Plasma Human Up
Study M1087 Type1 CSDS group vs. control group Faece C57BL/6 mouse Down
Study M1090 Type2 CUMS + hyperbaric oxygen treatment group vs. CUMS group Plasma BALb/c mouse Down
Study M1098 Type1 CUMS group vs. control group Serum Sprague-Dawley rat Down
Study M1098 Type2 CUMS + L-theanine group vs. CUMS group Serum Sprague-Dawley rat Up
Study M147 Type2 FSL sustained fluoxetine group vs. FSL sustained control group Brain Sprague-Dawley rat Down
Study M147 Type2 FSL sustained vortioxetine group vs. FSL sustained control group Brain Sprague-Dawley rat Down
Study M147 Type2 FSL sustained fluoxetine group vs. FSL sustained control group Cerebellum Sprague-Dawley rat Down
Study M147 Type2 FSL sustained vortioxetine group vs. FSL sustained control group Cerebellum Sprague-Dawley rat Down
Study M147 Type3 SD sustained vortioxetine group vs. SD sustained control group Brain Sprague-Dawley rat Down
Study M147 Type3 SD sustained fluoxetine group vs. SD sustained control group Cerebellum Sprague-Dawley rat Down
Study M147 Type3 SD sustained vortioxetine group vs. SD sustained control group Cerebellum Sprague-Dawley rat Down
Study M147 Type3 SD sustained fluoxetine group vs. SD sustained control group Brain Sprague-Dawley rat Down
Study M151 Type1 Female FSL group vs. Female FRL group Brain Sprague-Dawley rat Down
Study M516 Type1 SMG-treated group vs. control group Urine Sprague-Dawley rat Down
Study M583 Type1 PSD group vs. control group Hippocampus Sprague-Dawley rat Down
Study M583 Type2 PSD group, after vs. before fluoxetine treatment Hippocampus Sprague-Dawley rat Up
Study M594 Type1 CRS group vs. control group Entorhinal cortex C57BL/6 mouse Up
Study M598 Type1 MS group vs. control group Brain Sprague-Dawley rat Up
Study M633 Type1 corticosterone group vs. control group Urine C57BL/6 mouse Down
Study M672 Type1 SMG group vs. control group Urine Sprague-Dawley rat Down
Study M701 Type1 MDD group vs. control group Plasma Human Down
Study M722 Type1 CUMS-transferred group vs. control-transferred group Serum C57BL/6J mouse Down
Study M722 Type1 CUMS-transferred group vs. control-transferred group Hippocampus C57BL/6J mouse Down
Study M722 Type2 CUMS-transferred group + 5-hydroxytryptophan group vs. CUMS-transferred group Hippocampus C57BL/6J mouse Up
Study M722 Type2 CUMS-transferred group + 5-hydroxytryptophan group vs. CUMS-transferred group Serum C57BL/6J mouse Up
Study M777 Type1 HFCS-MFD group vs. control group Serum C57Bl/6J mouse Down
Study M850 Type1 reserpine group vs. control group Brain C57BL/6 mouse Up
Study M920 Type1 anhedonia-susceptible group vs. control grou Nucleus accumbens Sprague-Dawley rat Up
Study M980 Type1 CMS group vs. control group Olfactory bulb C57BL/6J mouse Down